跳至主要内容
临床试验/NCT01011504
NCT01011504已完成不适用

A Registry Study to Determine Utilisation Patterns in Patients Receiving Angiox®, and Collect Descriptive Safety and Outcome Data to Inform the Risk Management Strategy for Europe.

The Medicines Company2 个研究点 分布在 2 个国家目标入组 2,019 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,019
试验地点
2
主要终点
Posology and usage patterns of Angiox®: Dose(s) and time of bolus and infusion administered

研究概览

简要总结

The objective of this study is to determine utilisation patterns in patients receiving Angiox® in participating European centres. Additionally, through the collection of descriptive safety and outcomes data, this study will contribute to the Risk Management strategy for Europe

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Eligible for, and receive treatment with Angiox®.
  • •Willing and able to provide written informed consent to the use of their data in accordance with relevant local Data Protection laws, policies and regulations

排除标准

  • •Participation in other interventional clinical research studies involving the evaluation of investigational drugs, including Angiox®, or devices at the time of enrolment.
  • •Patients not eligible for treatment for Angiox®.

结局指标

主要结局

Posology and usage patterns of Angiox®: Dose(s) and time of bolus and infusion administered

时间窗: from hospital admission until hospital discharge, or 7 days after administration (which ever is earlier).

次要结局

  • Death Myocardial infarction Unplanned revascularisation Stroke Major* and minor bleeding Thrombocytopenia Stent thrombosis Adverse events and serious adverse events(measured in-hospital (prior to discharge), and at post-hospital discharge in outpatient as per local practice (30 days))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验